Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Schizophrenia

  Free Subscription


25.05.2026

1 Acta Psychiatr Scand
2 J Clin Psychiatry
1 J Psychiatry Neurosci
5 Mol Psychiatry
1 Pharmacopsychiatry
1 PLoS One
1 Psychiatry Res
7 Schizophr Res


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Psychiatr Scand

  1. BAEZA I, Tor J, de la Serna E, Sugranyes G, et al
    Impact of Obstetric Complications in Subjects at Clinical High Risk for Psychosis: A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2025;152:81-93.
    PubMed         Abstract available


    J Clin Psychiatry

  2. KUMAR N, Prasad S, Srivastava MVP, Kalaivani M, et al
    Effects of Experimental Intermittent Theta Burst Stimulation on Negative Symptoms of Schizophrenia: A Double-Blind Sham-Controlled Study.
    J Clin Psychiatry. 2026;87:25m16093.
    PubMed         Abstract available

  3. CITROME L, Bell Lynum KS, Zhang Z, Atkins N Jr, et al
    Aripiprazole Once-Monthly for Patients Diagnosed With Schizophrenia: Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed.
    J Clin Psychiatry. 2026;87:26m16359.
    PubMed         Abstract available


    J Psychiatry Neurosci

  4. HAN Y, Du Y, Xia Y, Hua L, et al
    Dual-pathway inhibitory dysfunction in schizophrenia: MEG and behavioral markers for risk stratification.
    J Psychiatry Neurosci. 2026;51:1-14.
    PubMed         Abstract available


    Mol Psychiatry

  5. BARENDSE MEA, Poortman SR, Ching CRK, Cahn W, et al
    White matter microstructure in relatives of people with schizophrenia or bipolar disorder: an ENIGMA meta-analysis.
    Mol Psychiatry. 2026 May 21. doi: 10.1038/s41380-026-03628.
    PubMed         Abstract available

  6. OWEN MJ, O'Donovan MC
    Rethinking schizophrenia: insights from genomics and implications for research.
    Mol Psychiatry. 2026 May 21. doi: 10.1038/s41380-026-03654.
    PubMed         Abstract available

  7. NERLAND S, Barth C, Jorgensen KN, Wortinger LA, et al
    Cerebral cortical alterations in adolescent early-onset psychosis: a surface-based morphometry mega-analysis.
    Mol Psychiatry. 2026 May 19. doi: 10.1038/s41380-026-03641.
    PubMed         Abstract available

  8. LUTHER L, Cooper JA, Treadway MT, Knippenberg AR, et al
    Computational phenotypes underlying effort-based decision-making and negative symptoms in a transdiagnostic severe mental illness sample.
    Mol Psychiatry. 2026;31:3435-3445.
    PubMed         Abstract available

  9. XUE H, Lei M, Zhao Q, Zhang Z, et al
    Powering the mind: deciphering the shared genetic architecture between mitochondrial DNA copy number and major psychiatric disorders.
    Mol Psychiatry. 2026;31:3127-3138.
    PubMed         Abstract available


    Pharmacopsychiatry

  10. HART XM, Hirjak D, Eap CB, Eichentopf L, et al
    High Clozapine Serum Levels Do Not Improve Response: An Observational Study in Patients with Schizophrenia Treated with Clozapine in a Naturalistic Setting.
    Pharmacopsychiatry. 2026 May 20. doi: 10.1055/a-2868-3000.
    PubMed         Abstract available


    PLoS One

  11. FENG Y, Wang Y, Wang B
    An exploratory study on cortical hemodynamics and handgrip strength phenotypes in long-term hospitalized patients with stable schizophrenia.
    PLoS One. 2026;21:e0349442.
    PubMed         Abstract available


    Psychiatry Res

  12. YANG Y, Zhu Y, Wu R, Jiang F, et al
    Short-term development of neurocognition in early-stage schizophrenia with predominant negative symptoms.
    Psychiatry Res. 2026;363:117230.
    PubMed         Abstract available


    Schizophr Res

  13. STRAUSS GP, Zhang Z, Arnold LE, Hutcheson AL, et al
    Subjective perceptions of negative symptoms among outpatients with schizophrenia and their relatives or caregivers: Definitions, importance, measurement, and desired improvement.
    Schizophr Res. 2026;295:61-71.
    PubMed         Abstract available

  14. FOO CYS, Leonard CJ, McLaughlin MM, Johnson KA, et al
    A mixed methods study of program-level factors influencing patient and family engagement in first episode psychosis coordinated specialty care.
    Schizophr Res. 2026;295:52-60.
    PubMed         Abstract available

  15. SUN L, Bo Y, Li D, Yao P, et al
    Plasma metabolomic signature of frailty and risk of late-onset schizophrenia: A prospective cohort study.
    Schizophr Res. 2026;295:29-38.
    PubMed         Abstract available

  16. WANG J, Yang M, Wang Z, Xue K, et al
    Changes in neurovascular coupling of cerebral blood flow and functional connectivity strength in first-episode schizophrenia patients after antipsychotic treatment.
    Schizophr Res. 2026;295:11-20.
    PubMed         Abstract available

  17. RICH HM, Pokorny VJ, Osborne KJ, Geiger M, et al
    Atypical semantic priming in individuals at clinical risk for psychosis.
    Schizophr Res. 2026;295:3-10.
    PubMed         Abstract available

  18. IGARASHI Y, Norii T, Ohno E, Wakisaka R, et al
    Foreign body airway obstruction in schizophrenia: Findings from a prospective multicenter registry.
    Schizophr Res. 2026;295:1-2.
    PubMed        

  19. KIRPINAR MM, Aksoy Poyraz C, Yildirim I, Polat CD, et al
    Predictors of early discontinuation of clozapine under rapid titration in a Turkish tertiary inpatient setting.
    Schizophr Res. 2026;293:8-16.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum